🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 9 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
08/12/1997 49,80 50,07 49,44 49,98 +0,24% 1,26% 5.700.282
05/12/1997 49,29 49,92 48,54 49,86 -0,12% 2,78% 9.102.928
04/12/1997 49,38 50,10 48,90 49,92 +6,76% 2,42% 20.388.002
03/12/1997 45,29 46,88 45,24 46,76 +3,02% 3,62% 12.406.853
02/12/1997 45,47 45,68 45,24 45,38 -0,20% 0,98% 8.859.792
01/12/1997 45,32 45,50 45,21 45,47 +0,51% 0,66% 7.230.990
28/11/1997 45,21 45,32 45,12 45,24 +0,75% 0,46% 1.564.664
26/11/1997 44,85 45,21 44,70 44,91 +0,20% 1,13% 4.857.061
25/11/1997 44,67 45,06 44,31 44,82 +1,55% 1,67% 7.926.862
24/11/1997 44,79 45,00 43,71 44,13 -2,18% 2,86% 7.191.586
21/11/1997 44,13 45,18 43,62 45,12 +2,16% 3,51% 10.782.872
20/11/1997 44,76 45,41 44,13 44,16 -0,27% 2,86% 8.195.779
19/11/1997 43,24 44,64 43,15 44,28 +2,41% 3,45% 5.433.042
18/11/1997 43,54 44,01 43,12 43,24 -0,82% 2,05% 5.189.067
17/11/1997 43,42 43,98 43,39 43,59 +1,18% 1,37% 7.359.266
14/11/1997 41,95 43,24 41,90 43,09 +2,70% 3,20% 7.746.606
13/11/1997 41,81 42,10 40,70 41,95 +1,15% 3,35% 9.136.883
12/11/1997 41,98 42,64 41,15 41,48 -1,90% 3,55% 8.064.360
11/11/1997 42,13 42,82 42,13 42,28 +0,14% 1,63% 5.512.690
10/11/1997 42,94 43,18 42,10 42,22 -0,28% 2,50% 7.219.462
07/11/1997 41,75 42,67 41,57 42,34 +0,00% 2,64% 8.690.854
06/11/1997 42,04 42,64 41,93 42,34 +1,00% 1,70% 7.463.646
05/11/1997 41,98 42,31 41,57 41,93 -0,35% 1,78% 8.598.630
04/11/1997 43,06 43,24 42,04 42,07 -2,56% 2,77% 6.506.822
03/11/1997 43,15 43,36 42,70 43,18 +1,40% 1,52% 6.624.408
31/10/1997 42,28 42,88 41,84 42,58 +2,00% 2,47% 6.688.546
30/10/1997 41,98 43,15 38,47 41,75 -1,34% 11,15% 7.623.152
29/10/1997 42,64 43,33 42,04 42,31 +0,92% 3,01% 11.973.819
28/10/1997 39,12 42,94 39,12 41,93 +3,38% 9,76% 23.196.432
27/10/1997 43,18 43,21 40,55 40,55 -8,97% 6,15% 16.099.586